Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1998-06-29
2000-04-11
Kumar, Shailendra
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
564194, 564196, A61K 3116, A61K 31165, C07C23506, C07C23305
Patent
active
060488999
ABSTRACT:
The present invention is directed to N-benzyl-2-amino-3-methoxypropionamide and stereoisomers the use thereof anti-convulsant and an intermediate in the preparation of other anti-convulsants.
REFERENCES:
patent: 5153226 (1992-10-01), Chucholowski et al.
patent: 5378729 (1995-01-01), Kohn et al.
patent: 5654301 (1997-08-01), Kohn et al.
patent: 5814669 (1998-09-01), Stelzer et al.
Kohn, Harold et al. "Preparation and anticonvulsant activity of a series of functionalized. alpha.--heteroatom-substituted amino acids", J. Med. Chem., 1991, 34, 2444-2452.
Kohn, Harold et al. "Marked stereospecificity in a new class of anticonvulsants", Chemical Abstracts, 1988, 109, Abstract No. 183045.
Choi, Daeock et al. "Synthesis and Anticonvulsant Activities of N-Benzyl-2-acetamidopropionamide Derivatives", J. Med. Chem., 1996, 39, 1907-1916.
Andurkar Shridhar V.
Kohn Harold
Kumar Shailendra
Research Corporation Tech. Inc.
LandOfFree
Anticonvulsant enantiomeric amino acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anticonvulsant enantiomeric amino acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anticonvulsant enantiomeric amino acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1177148